Committees

Ulf Bergman, Karolinska University, Sweden
K. Arnold Chan, National Taiwan University, Taiwan
Mark Epstein, Executive Secretary, ISPE – USA
Tobias Gerhard, Rutgers University, NJ, USA
Robert Hay, Executive Assistant, ISPE, USA
Yea-Huei Kao Yang, National Cheng Kung University, Taiwan
Koji Kawakami, Kyoto University, Japan
Maarit Korhonen, Monash University, Australia
Kiyoshi Kubota, President – ISPE, Japan
Kirk Midkiff, RTI Health Solutions, NC, USA
Byung Joo Park, Korea Institute of Drug Safety and Risk Management, Korea
G Parthasarathi, JSS University, Mysore, India

Syd Phillips, QuintilesIMS, WA, USA
Soko Setoguchi, Rutgers University, NJ, USA
Syed Rizwanuddin Ahmad, Georgetown University MD, USA
Shiro Tanaka, Kyoto University, Japan
Sawaeng Watcharathanakij, Ubon Ratchathani University, Thailand
Ian Chi Kei Wong, University of Hong Kong, China
Songlin Xue, Astellas, Chicago USA
Siyan Zhan, Peking University, China
Wei Zhou, Merck, PA, USA

Zandy Clavarino, The University of Queensland
Judith Coombes, The University of Queensland
Genevieve Gabb, Royal Adelaide Hospital
Jasmina Fejzic, The University of Queensland
Natasa Gisev, University of New South Wales
Richard Hill, Therapeutic Goods Administration, Department of Health
Samantha Hollingworth, The University of Queensland
Jenni Ilomäki, Monash University
Anna Kemp, The University of Western Australia
Maarit Korhonen, University of Turku
Adam La Caze, The University of Queensland
Peter J Little AM, The University of Queensland

John McEwen, University of Canberra
Treasure McGuire, The University of Queensland
Leigh McKauge,  The University of Queensland
Sallie Pearson, University of New South Wales
Lisa Pont, FISPE, Macquarie University
Nicole Pratt, University of South Australia
Debra Rowett, Drug and Therapeutics Information Service
Christine Staatz, The University of Queensland
Meng-Wong Taing, The University of Queensland
Lynn Weekes AM, NPS MedicineWise
Margaret Williamson, Health Research & Evaluation Services